Antimalarial chemotherapeutic peroxides: Artemisinin, yingzhaosu A and related compounds

International Journal for Parasitology

Volumn 32, Issue 13, 2002, Pages 1661-1667

  Borstnik, Kristina ^a   Paik, Ik Hyeon ^a   Shapiro, Theresa A ^b   Posner, Gary H ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Division of Clinical Pharmacology   (United States)

Author keywords

Artemisinin; Chemotherapy; Malaria; Plasmodium; Rational design of drugs; Trioxanes; Yingzhaosu A

Indexed keywords

ANTIMALARIAL AGENT; ARTEETHER; ARTEFLENE; ARTELINIC ACID; ARTEMETHER; ARTEMISININ; ARTESUNATE; ENDOPEROXIDE;

DRUG DEVELOPMENT; MALARIA;

CHEMOTHERAPY; CONFERENCE PAPER; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG SYNTHESIS; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM;

ANIMALS; ANTIMALARIALS; ARTEMISININS; BICYCLO COMPOUNDS, HETEROCYCLIC; DRUG DESIGN; PEROXIDES; PLASMODIUM; SESQUITERPENES;

EID: 0037021402     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(02)00195-9     Document Type: Conference Paper

References (61)

1. Abouabdellah A., Begue J.-P., Bonnet-Delpon D., Gantier J.-C., Nga T.T.T., Thac T.D. Synthesis and in vivo antimalarial activity of 12α-trifluoromethyl-hydroartemisinin. Bioorg. Med. Chem. Lett. 6:1996;2717-2720.
2. Avery M.A., Gao F., Chong W.K.M., Mehrotra S., Jennings-White C. The organic and medicinal chemistry of artemisinin and analogues. Trends Org. Chem. 4:1993;413-468.
3. Bachi M.D., Korshin E.E. Thiol-oxygen cooxidation of monoterpenes. Synthesis of endoperoxides structurally related to antimalarial Yingzhaosu A. Synlett. 1998;122-124.
4. Bachi M.D., Korshin E.E., Ploypradith P., Cumming J.N., Xie S., Shapiro T.A., Posner G.H. Synthesis and in vitro antimalarial activity of sulfone endoperoxides. Bioorg. Med. Chem. Lett. 8:1998;903-908.
5. Bachi M.D., Korshin E.E., Hoos R., Szpilman A.M. Synthesis and reactions of antimalarial bicyclic peroxides. J. Heterocyclic Chem. 37:2000;639-646.
6. Barradell L.B., Fitton A. Artesunate: a review of its pharmacology and therapeutic efficacy in the treatment of malaria. Drugs. 50:1995;714-741.
7. Bishop L.P.D., Maggs J.L., O'Neill P.M., Park B.K. Metabolism of the antimalarial endoperoxide Ro 42-1611 (arteflene) in the rat: evidence for endoperoxide bioactivation. J. Pharm. Expt. Ther. 289:1999;511-520.
8. Brewer T.G., Peggins J.O., Grate S.J., Petras J.M., Levine B.S., Weina P.J., Swearengen J., Heiffer M.H., Schuster B.G. Neurotoxicity in animals due to arteether and artemether. Trans. R. Soc. Trop. Med. Hyg. 88:(Suppl. 1):1994;33-36.
9. Chi H.T., Ramu K., Baker J.K., Hufford C.D., Lee I.S., Yan-Lin Z., McChesney J.D. Identification of the in vivo metabolites of the antimalarial arteether by thermospray high-performance liquid chromatography/mass spectrometry. Biol. Mass. Spectrom. 20:1991;609-628.
10. China Cooperative Research Group on Qinghaosu and Its Derivatives as Antimalarials . The chemistry and synthesis of qinghaosu derivatives. J. Trad. Chin. Med. 2:1982;9-16.
11. China Cooperative Research Group on Qinghaosu and Its Derivatives as Antimalarials . Studies on the toxicity of qinghaosu and its derivatives. J. Trad. Chin. Med. 2:1985;31-38.
12. Dong Y., Matile H., Chollet J., Kaminsky R., Wood J.K., Vennerstrom J.L. Synthesis and antimalarial activity of 11 dispiro-1,2,4,5-tetraoxane analogues of WR 148999. 7,8,15,16-Tetraoxadispiro[5.2.5.2] hexadecanes substituted at the 1 and 10 positions with unsaturated and polar functional groups. J. Med. Chem. 42:1999;1477-1480.
13. Fleck S.L., Robinson B.L., Peters W., Thevin F., Boulard Y., Glenat C., Caillard V., Landau I. The chemotherapy of rodent malaria. LIII. 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3′-spirocyclopentane 1,2,4-trioxane: comparison with some compounds of the artemisinin series. Ann. Trop. Med. Parasitol. 91:1997;25-32.
14. Haynes R.K. Artemisinin and derivatives: the future for malaria treatment? Curr. Opin. Infect. Dis. 14:2001;719-726.
15. Hien T.T., White N.J. Qinghaosu. Lancet. 341:1993;603-608.
16. Hofheinz W., Burgin H., Gocke E., Jaquet C., Masciadri R., Schmid G., Stohler H., Urwyler H. Ro42-1611 (arteflene), a new effective antimalarial: chemical structure and biological activity. Trop. Med. Parasitol. 45:1994;261-265.
17. Jaquet C., Stohler H.R., Chollet J., Peters W. Antimalarial activity of the bicyclic peroxide Ro 42-1611 (arteflene) in experimental models. Trop. Med. Parasitol. 45:1994;266-271.
18. Jefford C.W., McGoran E.C., Boukouvalas J., Richardson G., Robinson B.L., Peters W. Synthesis of new 1,2,4-trioxanes and their antimalarial activity. Helv. Chim. Acta. 71:1988;1805-1812.
19. Jefford C.W., Velarde J.A., Bernardinelli G., Bray D.H., Warhurst D.C., Milhous W.K. Synthesis, structure, and antimalarial activity of tricyclic 1,2,4-trioxanes related to artemisinin. Helv. Chim. Acta. 76:1993;2775-2788.
20. Jefford C.W., Jaggi D., Kohmoto S., Timari G., Bernardinelli G., Canfield C.J., Milhous W.K. The structure and antimalarial activity of some cis-fused 1,2,4-trioxane derivatives. Heterocycles. 49:1998;375-383.
21. Jung M., Lee S. A concise synthesis of novel aromatic analogues of artemisinin. Heterocycles. 45:1997;1055-1058.
22. Jung M., Bae J. An efficient synthesis of new analogues of water-soluble and hydrolytically stable deoxoartemisinin. Heterocycles. 53:2000;261-264.
23. Jung M., Li X., Bustos D.A., ElSohly H.N., McChesney J.D., Milhous W.K. Synthesis and antimalarial activity of (+)-deoxoartemisinin. J. Med. Chem. 33:1990;1516-1518.
24. Jung M., Bustos D.A., ElSohly H.N., McChesney J.D. A concise and stereoselective synthesis of (+)-12-n-butyldeoxoartemisinin. Synlett. 1990;743-744.
25. Jung M., Lee K., Jung H. First synthesis of (+)-deoxoartemisitene and its novel C-11 derivatives. Tetrahedron Lett. 42:2001;3997-4000.
26. Katz E., Ma J., Kyle D., Ziffer H. Structure and antimalarial activity of adducts of 11-azaartemisinin with conjugated terminal acetylenes. Bioog. Med. Chem. Lett. 9:1999;2969-2972.
27. Kim H.-S., Shibata Y., Wataya Y., Tsuchiya K., Masuyama A., Nojima M. Synthesis and antimalarial activity of cyclic peroxides, 1,2,4,5,7-pentoxocanes and 1,2,4,5-tetroxanes. J. Med. Chem. 42:1999;2604-2609.
28. Kim H.-S., Nagai Y., Ono K., Begum K., Wataya Y., Hamada Y., Tsuchiya K., Masuyama A., Nojima M., McCoullough K.J. Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes. J. Med. Chem. 44:2001;2357-2361.
29. Li Q., Peggins J.O., Lin A.J., Masonic K.J., Trotman K.M., Brewer T.G. Pharmacology and toxicology of artelinic acid: preclinical investigations on pharmacokinetics, metabolism, protein and red blood cell binding, and acute and anorectic toxicities. Trans. R. Soc. Trop. Med. Hyg. 92:1998;332-340.
30. Lin A.J., Miller R.E. Antimalarial activity of new dihydroartemisinin derivatives. 6. α-alkylbenzylic ethers. J. Med. Chem. 38:1995;764-770.
31. Lin A.J., Klayman D.L., Milhous W.K. Antimalarial activity of new water-soluble dihydroartemisinin derivatives. J. Med. Chem. 30:1987;2147-2150.
32. Lin A.J., Lee M., Klayman D.L. Antimalarial activity of new water-soluble dihydroartemisinin derivatives. 2. Stereospecificity of the ether side chain. J. Med. Chem. 32:1989;1249-1252.
33. Lin A.J., Zikry A.B., Kyle D.E. Antimalarial activity of new dihydroartemisinin derivatives. 7. 4-(p-Substituted phenyl)-4(R or S)-[10(α or β)-dihydroartemisininoxy]butyric acids. J. Med. Chem. 40:1997;1396-1400.
34. Ma J., Katz E., Kyle D.E., Ziffer H. Syntheses and antimalarial activities of 10-substituted deoxoartemisinins. J. Med. Chem. 43:2000;4228-4232.
35. Ma J., Weiss E., Kyle D.E., Ziffer H. Acid catalysed Michael additions to artemisitene. Bioorg. Med. Chem. Lett. 10:2000;1601-1603.
36. McCullough K.J., Nonami Y., Masuyama A., Nojima M., Kim H.-S., Wataya Y. Synthesis, crystal structure and antimalarial activity of novel 1,2,5,6-tetraoxacycloalkanes from 2,3-dihydroperoxy-2-phenylnorbornane. Tetrahedron Lett. 40:1999;9151-9155.
37. Mekonnen B., Weiss E., Katz E., Ma J., Ziffer H., Kyle D.E. Synthesis and antimalarial activities of base-catalysed adducts of 11-azaartemisinin. Bioorg. Med. Chem. Lett. 8:2000;1111-1116.
38. Meshnick S.R., Jefford C.W., Posner G.H., Avery M.A., Peters W. Second-generation antimalarial endoperoxides. Parasitol. Today. 12:1996;79-82.
39. O'Neill P.M., Searle N.L., Raynes K.J., Maggs J.L., Ward S.A., Storr R.C., Park B.K., Posner G.H. A carbonyl oxide route to antimalarial Yinzhaosu A analogues: synthesis and antimalarial activity. Tetrahedron Lett. 39:1998;6065-6068.
40. 4 activator system to the synthesis of novel, potent, C-10 phenoxy derivatives of dihydroartemisinin. Tet. Lett. 40:1999;9129-9132.
41. O'Neill P.M., Miller A., Bishop L.P.D., Hindley S., Maggs J.L., Ward S.A., Roberts S.M., Scheinmann F., Stachulski A.V., Posner G.H., Park B.K. Synthesis, antimalarial activity, biomimetic iron(II) chemistry, and in vivo metabolism of novel, potent, C-10-phenoxy derivatives of dihydroartemisinin. J. Med. Chem. 44:2001;58-68.
42. Peters W., Robinson B.L., Rossier J.C., Jefford C.W. The chemotherapy of rodent malaria. XLVIII. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 1: Studies leading to the development of novel cis-fused cyclopenteno derivatives. Ann. Trop. Med. Parasitol. 87:1993;1-7.
43. Peters W., Robinson B.L., Rossier J.C., Misra D., Jefford C.W. The chemotherapy of rodent malaria. XLIX. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 2: Structure-activity studies on cis-fused cyclopeteno-1,2,4-trioxanes (fenozans) against drug-sensitive and drug-resistant lines of Plasmodium berghei and P. yoelii ssp. NS in vivo. Ann. Trop. Med. Parasitol. 87:1993;9-16.
44. Posner G.H., Oh C.H., Genera L., Milhous W.K. Extraordinarily potent antimalarial compounds: new, structurally simple, easily synthesised, tricyclic 1,2,4-trioxanes. J. Med. Chem. 35:1992;2459-2467.
45. Posner G.H., Wang D., Cumming J.N., Oh C.H., French A.N., Bodley A.L., Shapiro T.A. Further evidence supporting the importance of and the restrictions on a carbon-centered radical for high antimalarial activity of 1,2,4-trioxanes like artemisinin. J. Med. Chem. 38:1995;2273-2275.
46. Posner G.H., O'Dowd H., Ploypradith P., Cumming J.N., Xie S., Shapiro T.A. Antimalarial cyclic peroxy ketals. J. Med. Chem. 41:1998;2164-2167.
47. Posner G.H., Cumming J.N., Woo S.-H., Ploypradith P., Xie S., Shapiro T.A. Orally active antimalarial 3-substituted trioxanes: new synthetic methodology and biological evaluation. J. Med. Chem. 41:1998;940-951.
48. Posner G.H., Parker M.H., Northrop J., Elias J.S., Ploypradith P., Xie S., Shapiro T.A. Orally active, hydrolytically stable, semisynthetic, antimalarial trioxanes in the artemisinin family. J. Med. Chem. 42:1999;300-304.
49. Posner G.H., Ploypradith P., Parker M.H., O'Dowd M.H., Woo S.-H., Northrop J., Krasavin M., Dolan P., Kensler T.W., Xie S., Shapiro T.A. Antimalarial, antiproliferative, and antitumor activities of artemisinin-derived, chemically robust, trioxane dimers. J. Med. Chem. 42:1999;4275-4280.
50. Posner G.H., Jeon H.B., Parker M.H., Krasavin M., Paik I.-H., Shapiro T.A. Antimalarial simplified 3-aryltrioxanes: synthesis and preclinical efficacy/toxicity testing in rodents. J. Med. Chem. 44:2001;3054-3058.
51. Pu Y.M., Ziffer H. Synthesis and antimalarial activities of 12β-allyldeoxoartemisinin and its derivatives. J. Med. Chem. 38:1995;613-616.
52. Pu Y.M., Torok D.S., Ziffer H., Pan X.-Q., Meshnick S.R. Synthesis and antimalarial activities of several fluorinated artemisinin derivatives. J. Med. Chem. 38:1995;4120-4124.
53. Torok D.S., Ziffer H., Meshnick S.R., Pan X.-Q. Synthesis and antimalarial activities of N-substituted 11-azaartemisinins. J. Med. Chem. 38:1995;5045-5050.
54. Tsuchiya K., Hamada Y., Masuyama A., Nojima M., McCullough K.J., Kim H.-S., Shibata Y., Wataya Y. Synthesis, crystal structure and anti-malarial activity of novel spiro-1,2,4,5-tetraoxacycloalkanes. Tetrahedron Lett. 40:1999;4077-4080.
55. van Vianen P.H., Klayman D.K., Lin A.J., Lugt C.B., van Engen A.L., van der Kaay H.J., Mons B. Plasmodium berghei: the antimalarial action of artemisinin and sodium artelinate in vivo and in vitro, studied by flow cytometry. Exp. Parasitol. 70:1990;115-123.
56. Vennerstrom J.L., Fu H.-N., Ellis W.Y., Ager A.L. Jr, Wood J.K., Anderson S.L., Gerena L., Milhous W.K. Dispiro-1,2,4,5-tetraoxanes: a new class of antimalarial peroxides. J. Med. Chem. 35:1992;3023-3027.
57. Vennerstrom J.L., Dong Y., Anderson S.L., Ager A.L. Jr, Fu H.-N., Miller R.E., Wesche D.L., Kyle D.E., Gerena L., Walters S.M., Wood J.K., Edwards G., Holme A.D., Mclean W.G., Milhous W.K. Synthesis and antimalarial activity of 16 dispiro-1,2,4,5-tetraoxanes: alkyl-substituted 7,8,15,16-tetraoxadispiro[5.2.5.2]hexadecanes. J. Med. Chem. 43:2000;2753-2758.
58. Vennerstrom J.L., Ager A.L. Jr, Anderson S.L., Steven L.G., James M., Wongpanich V., Angerhofer C.K., Hu J.K., Wesche D.L. Assessment of the antimalarial potential of tetraoxane WR 148999. Am. J. Trop. Med. Hyg. 62:2001;573-578.
59. Venogupalan B., Bapat C.P., Karnik P.J., Chatterjee D.K., Iyer N., Lepcha D. Antimalarial activity of novel ring-contracted artemisinin derivatives. J. Med. Chem. 38:1995;1922-1927.
60. Wang D.-Y., Wu Y., Wu Y.-Y., Li Y., Shan F. Synthesis, iron(II)-induced cleavage and in vivo antimalarial efficacy of 10-(2-hydroxy-1-naphthyl)-deoxoqinghaosu (-deoxoartemisinin). J. Chem. Soc., Perin Trans. 1:1999;1827-1831.
61. Ziffer H., Highet R.J., Klayman D.L. Artemisinin: An endoperoxidic antimalarial from Artemisia annua L. Prog. Chem. Org. Nat. Prod. 72:1997;121-214.